These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 31396799)

  • 21. Safety and efficacy of buprenorphine/naloxone in opioid-dependent patients: an Italian observational study.
    Magnelli F; Biondi L; Calabria R; Fiore A; Peluso E; Vonella D; Rota AG
    Clin Drug Investig; 2010; 30 Suppl 1():21-6. PubMed ID: 20450242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intranasal naloxone for treatment of opioid overdose.
    Med Lett Drugs Ther; 2014 Mar; 56(1438):21-2. PubMed ID: 24662159
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical experience with fortnightly buprenorphine/naloxone versus buprenorphine in Italy: preliminary observational data in an office-based setting.
    Amato P
    Clin Drug Investig; 2010; 30 Suppl 1():33-9. PubMed ID: 20450244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An investigation of the ability of oral naloxone to correct opioid-related constipation in patients with advanced cancer.
    Sykes NP
    Palliat Med; 1996 Apr; 10(2):135-44. PubMed ID: 8800821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Naloxone pro-drug rescues morphine induced respiratory depression in Sprague-Dawley rats.
    Wallisch M; El Rody NM; Huang B; Koop DR; Baker JR; Olsen GD
    Respir Physiol Neurobiol; 2012 Jan; 180(1):52-60. PubMed ID: 22027217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of a high-dose target-controlled naloxone infusion on pain and hyperalgesia in patients following groin hernia repair: study protocol for a randomized controlled trial.
    Pereira MP; Werner MU; Dahl JB
    Trials; 2015 Nov; 16():511. PubMed ID: 26554360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A multicenter, 12-month, open-label, single-arm safety study of oxycodone-hydrochloride/naltrexone-hydrochloride extended-release capsules (ALO-02) in patients with moderate-to-severe chronic noncancer pain.
    Arora S; Setnik B; Michael D; Hudson JD; Clemmer R; Meisner P; Pixton GC; Goli V; Sommerville KW
    J Opioid Manag; 2014; 10(6):423-36. PubMed ID: 25531960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a Translational Model to Assess the Impact of Opioid Overdose and Naloxone Dosing on Respiratory Depression and Cardiac Arrest.
    Mann J; Samieegohar M; Chaturbedi A; Zirkle J; Han X; Ahmadi SF; Eshleman A; Janowsky A; Wolfrum K; Swanson T; Bloom S; Dahan A; Olofsen E; Florian J; Strauss DG; Li Z
    Clin Pharmacol Ther; 2022 Nov; 112(5):1020-1032. PubMed ID: 35766413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Clinical Study on Administration of Opioid Antagonists in Terminal Cancer Patients: 7 Patients Receiving Opioid Antagonists Following Opioids among 2443 Terminal Cancer Patients Receiving Opioids.
    Uekuzu Y; Higashiguchi T; Futamura A; Ito A; Mori N; Murai M; Ohara H; Awa H; Chihara T
    Biol Pharm Bull; 2017 Mar; 40(3):278-283. PubMed ID: 27980244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treament of morphine-induced constipation with oral naloxone].
    Latasch L; Zimmermann M; Eberhardt B; Jurna I
    Anaesthesist; 1997 Mar; 46(3):191-4. PubMed ID: 9163262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Importance of the correct diagnosis of opioid-induced respiratory depression in adult cancer patients and titration of naloxone.
    Boland J; Boland E; Brooks D
    Clin Med (Lond); 2013 Apr; 13(2):149-51. PubMed ID: 23681862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of pharmacodynamic effects following oral administration of crushed morphine sulfate and naltrexone hydrochloride extended-release capsules compared with crushed morphine sulfate controlled-release tablets and placebo in nondependent recreational opioid users.
    Setnik B; Sommerville K; Goli V; Han L; Webster L
    Pain Med; 2013 Aug; 14(8):1173-86. PubMed ID: 23745947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Naloxone formulation for overdose reversal preference among patients receiving opioids for pain management.
    Dunn KE; Barrett FS; Bigelow GE
    Addict Behav; 2018 Nov; 86():56-60. PubMed ID: 29625751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence from basic research for opioid combinations.
    Davis MP
    Expert Opin Drug Discov; 2012 Feb; 7(2):165-78. PubMed ID: 22468917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolonged-release naloxone can cause systemic opioid withdrawal.
    Wilcock A
    Eur J Pain; 2009 Oct; 13(9):1001; author reply 1002-3. PubMed ID: 19615925
    [No Abstract]   [Full Text] [Related]  

  • 36. Abuse-deterrent opioids: an update on current approaches and considerations.
    Pergolizzi JV; Raffa RB; Taylor R; Vacalis S
    Curr Med Res Opin; 2018 Apr; 34(4):711-723. PubMed ID: 29262730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An evaluation method for developing abuse-deterrent opioid formulations with agonist and antagonist combinations using conditioned place preference.
    Zhang X; Kitaichi K; Mouri A; Zhou X; Nabeshima T; Yamada K; Nagai T
    Biochem Biophys Res Commun; 2023 Jan; 639():100-105. PubMed ID: 36476949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence-Based Guidelines for EMS Administration of Naloxone.
    Williams K; Lang ES; Panchal AR; Gasper JJ; Taillac P; Gouda J; Lyng JW; Goodloe JM; Hedges M
    Prehosp Emerg Care; 2019; 23(6):749-763. PubMed ID: 30924736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Take-home naloxone treatment for opioid emergencies: a comparison of routes of administration and associated delivery systems.
    Elzey MJ; Fudin J; Edwards ES
    Expert Opin Drug Deliv; 2017 Sep; 14(9):1045-1058. PubMed ID: 27606669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Wooden chest syndrome: Beware of opioid antagonists, not just agonists.
    Levine R; Veliz S; Singer D
    Am J Emerg Med; 2020 Feb; 38(2):411.e5-411.e6. PubMed ID: 31831344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.